Vilas Transcore (VILAS)

FairStock Score: 53/100 — MIXED

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 40.84% and profit growth of 74.39% indicate strong demand and operating leverage.
• ROCE of 21.91% shows efficient use of capital and good returns on the industrial operations.
• Promoter holding of 73.21% aligns management interests with minority shareholders.
• Piotroski F-Score of 7/9 suggests improving fundamentals and financial health.
• PEG of 0.37 implies the current valuation does not fully price in the recent growth pace.

Concerns

• P/E of 21.35 with zero dividend leaves limited margin of safety if growth decelerates sharply.
• Debt/Equity and book value are not disclosed, making balance-sheet risk difficult to assess.
• Latest quarter profit of ₹24 Cr is a sharp jump; sustainability and quality of earnings need confirmation.
• Wide 52-week range of ₹320 to ₹604 highlights potential volatility and cyclicality.

AI Analysis

I look for a business I can understand and a management that thinks like owners. Vilas Transcore is an industrial products company growing at a fast clip. Sales are up 40.84% and profits are up 74.39%, with the latest quarter showing sales of ₹229 Cr and net profit of ₹24 Cr. That kind of profit leverage suggests operating leverage, pricing power, or both. ROCE of 21.91% is well above the threshold I normally demand; the company is earning good returns on the capital it uses. Promoters hold 73.21%, so their interests are closely tied to minority shareholders. At ₹469.30, the market cap is ₹960 Cr and the P/E is 21.35. That is not a bargain-shelf price, but with a PEG of 0.37, the market is paying surprisingly little for the growth if it continues. The Piotroski F-score of 7/9 also tells me the financials are improving on several dimensions. This is a fast grower with a small-cap risk profile. I would not yet call it a wide-moat business—industrial component manufacturers often face customer concentration and cyclicality—but the high ROCE and profit growth exceeding sales growth suggest some edge. The lack of a dividend does not bother me if capital is being deployed at a 21.91% ROCE. I would want to know more about the balance sheet, since debt-to-equity is not available, and I must never rely solely on a score. The 52-week range of ₹320 to ₹604 also reminds me that this stock will not move in a straight line. If growth normalises, a 21 P/E leaves little margin of safety. I would watch the next few quarters carefully before putting money to work.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer